Phototherapy: How does UV work?

Photodermatology Photoimmunology and Photomedicine

Volumn 21, Issue 5, 2005, Pages 260-266

  Weichenthal, Michael ^a   Schwarz, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Apoptosis; Cytokines; Immunosuppression; Mode of action; Phototherapy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 19; INTERLEUKIN 4; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; PSORALEN; STAT1 PROTEIN; STAT5 PROTEIN; UROCANIC ACID;

APOPTOSIS; ATOPIC DERMATITIS; CELL PROLIFERATION; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOTOXICITY; DNA DAMAGE; EXTRACELLULAR MATRIX; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; NONHUMAN; PHOTORECEPTOR; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; RADIATION ABSORPTION; RADIATION EXPOSURE; REVIEW; SCLERODERMA; SKIN ABSORPTION; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; URTICARIA PIGMENTOSA;

ANIMALS; HUMANS; IMMUNOSUPPRESSION; PHOTOBIOLOGY; PHOTOCHEMOTHERAPY; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 25844517883     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2005.00173.x     Document Type: Review

References (55)

1. Fischer T, Alsins J, Berne B. Ultraviolet action spectrum and evaluation of ultraviolet lamps for psoriasis healing. Br J Dermatol 1984; 23: 633-637.
2. Van Weelden H, Baart de la Faille H, Young A, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
3. Paul BS, Larkö O, Swanbeck G, Parrish JA. Therapeutic photomedicine: phototherapy. In: Fitzpatrick T, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. New York: McGraw-Hill Inc., 1993; 1717-1727.
4. Epstein JH. UVL-induced stimulation of DNA synthesis in hairless mouse epidermis. J Invest Dermatol 1968; 52: 445.
5. Kulms D, Schwarz T. Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 2000; 16: 195-201.
6. Kulms D, Pöppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to ultraviolet B radiation. Proc Natl Acad Sci USA 1999; 96: 7974-7979.
7. van Oosten M, Rebel H, Friedberg EC, et al. Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis. Proc Natl Acad Sci USA 2000; 97: 11268-11273.
8. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996; 274: 1194-1197.
9. Aragane Y, Kulms D, Metze D, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 1998; 140: 171-182.
10. Kulms D, Zeise E, Pöppelmann B, Schwarz T. DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 2002; 21: 5844-5851.
11. Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189: 711-718.
12. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997; 232: 255-262.
13. Mutzhas MF, Hölzle E, Hofman C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol 1981; 76: 42-47.
14. Krutmann J, Stege H, Morita A. Ultraviolet-A1 Phototherapy: Indications and mode of Action. In: Krutmann J, Hönigsmann H, Elmets CA, Bergstresser PR, eds. Dermatological phototherapy and photodiagnostic methods. Berlin: Springer, 2001; 261-276.
15. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768.
16. Plettenberg H, Stege H, Megahed M, et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999; 41: 47-50.
17. Zane C, Leali C, Airo P, De Panfilis G, Pinton PC. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-633.
18. Stege H, Schöpf E, Ruzicka T, Krutmann J. High-dose UVA1 for urticaria pigmentosa. Lancet 1996; 347: 64.
19. Gobello T, Mazzanti C, Sordi D, et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003; 49: 679-684.
20. Grabbe J, Welker P, Humke S, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422.
21. Luger TA, Schwarz T. Effects of UV-light on cytokines and neuroendocrine hormones. In: Elmets C, Krutmann J, eds. Photoimmunology. London: Backwell, 1995; 55-76.
22. Urbanski A, Schwarz T, Neuner P, et al. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 1990; 94: 808-811.
23. Ullrich SE. The role of epidermal cytokines in the generation of cutaneous immune reactions and ultraviolet radiation-induced immune suppression. Photochem Photobiol 1995; 62: 389-401.
24. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992; 149: 3865-3871.
25. Nishigori C, Yarosh DB, Ullrich SE, et al. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci USA 1996; 93: 10354-10359.
26. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-705.
27. Schlaak JF, Buslau M, Jochum W, et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-149.
28. Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998; 101: 783-794.
29. Ghoreschi K, Thomas P, Breit S, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-46.
30. Walters IB, Ozawa N, Cardinale I, et al. Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003; 139: 155-161.
31. Norval M, Gibbs NK, Gilmour J. The role of urocanic acid in UV-induced immunosuppression: recent advances (1992-1994). Photochem Photobiol 1995; 62: 209-217.
32. Beissert S, Mohammad T, Torri H, et al. Regulation of tumor antigen presentation by urocanic acid. J Immunol 1997; 159: 92-96.
33. Vestey JP, Norval M. An open trial of topical urocanic acid for the treatment of stable plaque psoriasis. Photodermatol Photoimmunol Photomed 1997; 13: 67-68.
34. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.
35. Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 1996; 10: 1578-1588.
36. Haspel RL, Salditt-Georgieff M, Darnell JE Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J 1996; 15: 6262-6268.
37. Aragane Y, Schwarz A, Luger TA, Kiyoshi A, Takashima A, Schwarz T. Ultraviolet light suppresses IFN-g-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors. J Immunol 1997; 158: 5393-5399.
38. Aragane Y, Kulms D, Luger TA, Schwarz T. Downregulation of interferon-g-activated STAT1 by ultraviolet ligh: Proc Natl Acad Sci USA. 1997; 94: 11490-11495.
39. Zamorano J, Wang YH, Wang R, Shi Y, Longmore GD, Keegan AD. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol 1998; 160: 3502-3512.
40. Chen EH, Massimo G, Galon J, Chen M, O'Shea JJ. Not just another meeting: the coming age of JAKs and STATs. Immunol Today 1998; 19: 338-341.
41. Kulms D, Schwarz T. Ultraviolet radiation inhibits interleukin-2-induced tyrosine phosphorylation and the activation of STAT5 in T lymhpocytes. J Biol Chem 2001; 276: 12849-12855.
42. Schwarz T. Photoimmunosuppression. Photodermatol Photoimmunol Photomed 2002; 18: 141-145.
43. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003; 171: 6323-6327.
44. Schwarz A, Maeda A, Wild MK, et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 2004; 172: 1036-1043.
45. Schwarz A, Beissert S, Grosse-Heitmeyer K, et al. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol 2000; 165: 1824-1831.
46. Aragane Y, Maeda A, Schwarz A, Tezuka T, Ariizumi K, Schwarz T. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J Immunol 2003; 171: 3801-3807.
47. Sleijiffers A, Garssen J, de Gruijl FR, et al. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J Invest Dermatol 2001; 117: 1144-1150.
48. Rook AH, Suchin KR, Kao DM, et al. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999; 4: 85-90.
49. Maeda A, Schwarz A, Kernebeck K, et al. Intraveneous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968-5976.
50. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
51. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296.
52. Ständer H, Schiller M, Schwarz T. UVA1-therapy for treatment of sclerodermic graft-versus-host-disease of the skin (Letter to the Editor). J Am Acad Dermatol 2002; 46: 799-800.
53. Fisher GJ, Schiller M, Schwarz T. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-339.
54. Wlaschek M, Bolsen K, Hermann G, et al. UVA-induced autocrine stimulation of fibroblast-derived-collagenase by IL-: a possible mechanism in dermal photodamage? J Invest Dermatol 1993; 101: 164-168.
55. Wlaschek M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharffetter-Kochanek K. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 1994; 59: 550-556.